Mojzych M - Search Results

1

1,2-Bis[1-(3-methyl-sulfanyl-1,2,4-triazin-5-yl)ethyl-idene]diazane.

Mojzych M, Karczmarzyk Z, Urbańczyk-Lipkowska Z, Kalicki P. Mojzych M, et al. Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 4;65(Pt 8):o1772. doi: 10.1107/S1600536809025033. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21583480 Free PMC article.

2

(E)-1-(Pyridin-2-yl)ethanone O-acryloyloxime.

Mojzych M, Karczmarzyk Z, Fruziński A. Mojzych M, et al. Acta Crystallogr Sect E Struct Rep Online. 2008 Mar 5;64(Pt 4):o653. doi: 10.1107/S1600536808005436. Acta Crystallogr Sect E Struct Rep Online. 2008. PMID: 21202050 Free PMC article.

3

1,3-Dimethyl-5-methyl-sulfonyl-1H-pyrazolo-[4,3-e][1,2,4]triazine.

Mojzych M, Karczmarzyk Z, Wysocki W. Mojzych M, et al. Acta Crystallogr Sect E Struct Rep Online. 2010 Nov 20;66(Pt 12):o3226. doi: 10.1107/S1600536810047264. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21589516 Free PMC article.

4

2-(5,6-Diphenyl-1,2,4-triazin-3-yl)aniline.

Mojzych M, Karczmarzyk Z, Fruziński A. Mojzych M, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Dec 1;68(Pt 12):o3278. doi: 10.1107/S1600536812044194. Epub 2012 Nov 3. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 23468791 Free PMC article.

5

New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity.

Mojzych M, Karczmarzyk Z, Wysocki W, Ceruso M, Supuran CT, Kryštof V, Urbańczyk-Lipkowska Z, Kalicki P. Mojzych M, et al. Bioorg Med Chem. 2015 Apr 1;23(7):1421-9. doi: 10.1016/j.bmc.2015.02.026. Epub 2015 Feb 21. Bioorg Med Chem. 2015. PMID: 25757603

6

Synthesis, Structural Characterization, and Biological Activity of New Pyrazolo[4,3-e][1,2,4]triazine Acyclonucleosides.

Mojzych M, Bernat Z, Karczmarzyk Z, Matysiak J, Fruziński A. Mojzych M, et al. Molecules. 2020 Jan 5;25(1):221. doi: 10.3390/molecules25010221. Molecules. 2020. PMID: 31948129 Free PMC article.

7

Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.

Mojzych M, Tarasiuk P, Karczmarzyk Z, Juszczak M, Rzeski W, Fruzinski A, Wozny A. Mojzych M, et al. Med Chem. 2018;14(1):53-59. doi: 10.2174/1573406413666171020114924. Med Chem. 2018. PMID: 29065838

8

Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-e][1,2,4]triazine Derivatives.

Bernat Z, Szymanowska A, Kciuk M, Kotwica-Mojzych K, Mojzych M. Bernat Z, et al. Among authors: mojzych m. Molecules. 2020 Aug 29;25(17):3948. doi: 10.3390/molecules25173948. Molecules. 2020. PMID: 32872493 Free PMC article. Review.

9

QSAR study of pyrazolo[4,3-e][1,2,4]triazine sulfonamides against tumor-associated human carbonic anhydrase isoforms IX and XII.

Matysiak J, Skrzypek A, Tarasiuk P, Mojzych M. Matysiak J, et al. Among authors: mojzych m. Comput Biol Chem. 2017 Dec;71:57-62. doi: 10.1016/j.compbiolchem.2017.09.006. Epub 2017 Sep 21. Comput Biol Chem. 2017. PMID: 28964980

10

Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro.

Bukowski K, Marciniak B, Kciuk M, Mojzych M, Kontek R. Bukowski K, et al. Among authors: mojzych m. Molecules. 2022 Jun 11;27(12):3761. doi: 10.3390/molecules27123761. Molecules. 2022. PMID: 35744887 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page